Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Jun 20;97(13):7058-63.
doi: 10.1073/pnas.97.13.7058.

Toward antibody-catalyzed hydrolysis of organophosphorus poisons

Affiliations

Toward antibody-catalyzed hydrolysis of organophosphorus poisons

P Vayron et al. Proc Natl Acad Sci U S A. .

Abstract

We report here our preliminary results on the use of catalytic antibodies as an approach to neutralizing organophosphorus chemical weapons. A first-generation hapten, methyl-alpha-hydroxyphosphinate Ha, was designed to mimic the approach of an incoming water molecule for the hydrolysis of exceedingly toxic methylphosphonothioate VX (1a). A moderate protective activity was first observed on polyclonal antibodies raised against Ha. The results were further confirmed by using a mAb PAR 15 raised against phenyl-alpha-hydroxyphosphinate Hb, which catalyzes the hydrolysis of PhX (1b), a less toxic phenylphosphonothioate analog of VX with a rate constant of 0.36 M(-1) x min(-1) at pH 7.4 and 25 degrees C, which corresponds to a catalytic proficiency of 14,400 M(-1) toward the rate constant for the uncatalyzed hydrolysis of 1b. This is a demonstration on the organophosphorus poisons themselves that mAbs can catalytically hydrolyze nerve agents, and a significant step toward the production of therapeutically active abzymes to treat poisoning by warfare agents.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hydrolysis reaction, hapten, and organophosphorus poisoning compounds structures.
Figure 2
Figure 2
Hapten synthesis. (i) EtOH, THF, 0°C; (ii) (7), EtN(i-Pr)2, DME, 50°C; (iii) H2, Pd/C 5%, EtOH/H2O 95/5; (iv) (a) acetone, MgSO4; (b) H2, Pd/C 5%, MeOH/acetone 50/50; (v) (8) Et3N, CH2Cl2.
Figure 3
Figure 3
Remaining AChE activity of a 0.6 nM AChE solution in EIA buffer treated with a 0.625 nM VX solution pretreated for 18 h with the corresponding mouse serum (1/100 diluted in EIA buffer) (a) before immunization, (b) after immunization, (c) after immunization and in presence of 50 μM hapten Ha, and (d) after immunization and in presence of 150 μM hapten Ha. Continuous and dashed lines represent means ± 2 SD for sera of 18 BALB/c mice preimmune or immunized with Hb, 5a, 5b, or unrelated haptens.
Figure 4
Figure 4
H3 and AChE inhibitors structures.
Figure 5
Figure 5
Hapten analogs.

References

    1. Taylor P. In: Anticholinesterase Agent in the Pharmacological Basis of Therapeutics. Goodman Gilman A, Rall T W, Nied A S, Taylor P, editors. New York: Pergamon; 1990.
    1. Bunton C A. In: Chemical Warfare in Macmillan Encyclopedia of Chemistry. Lagowski J J, editor. Vol. 1. New York: Macmillan; 1997. pp. 343–346.
    1. Yang Y C, Baker J A, Ward J R. Chem Rev. 1992;92:1729–1743.
    1. Millard C B, Lokridge O, Broomfield C A. Biochemistry. 1995;34:15925–15933. - PubMed
    1. Millard C B, Lokridge O, Broomfield C A. Biochemistry. 1998;37:237–247. - PubMed

Publication types

LinkOut - more resources